Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement

Breakthrough invasive fungal infections (bIFI) cause significant morbidity and mortality. Their diagnosis can be challenging due to reduced sensitivity to conventional culture techniques, serologic tests, and PCR-based assays in patients undergoing antifungal therapy, and their diagnosis can be dela...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenks, Jeffrey D., Gangneux, Jean-Pierre, Schwartz, Ilan S., Alastruey-Izquierdo, Ana, Lagrou, Katrien, Thompson, George R., Lass-Flörl, Cornelia, Hoenigl, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712958/
https://www.ncbi.nlm.nih.gov/pubmed/33050598
http://dx.doi.org/10.3390/jof6040216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712958/
https://www.ncbi.nlm.nih.gov/pubmed/33050598
http://dx.doi.org/10.3390/jof6040216

Ejemplares similares